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Penile metastasis from prostate cancer represents a rare condition, associated with poor
prognosis. In the literature, authors have reported less than 500 cases of secondary penile
cancers, and among these cases of metastases, only 33% are from prostate cancer. Overall
reported rate of survival is about 1-24 months. Here, we present an uncommon case of
penile metastasis from prostatic adenocarcinoma, with particular focus on the role of
computed tomography and magnetic resonance imaging in diagnosis and follow-up.
© 2016 the Authors. Published by Elsevier Inc. under copyright license from the University
of Washington. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).Case report
In December 2006, a 77-year-old male patient was treated
with radical prostatectomy and dissection of lymph nodes,
total adrenergic block (BAT), and cycles of radiation therapy
for prostate adenocarcinoma (Gleason score 5 þ 4 ¼ 9; T3b
N0 Mx).
During routine oncologic follow-up, his levels of serum
prostate-specific antigen (PSA) had remained below 1 ng/mLlared that no competing
m (G. Claroni).
Elsevier Inc. under copy
se (http://creativecommofor 6 years (normal values for PSA at our institution: 0-4.4 ng/
mL). In March 2012, the patient's value of PSA was 0.98 ng/mL.
In June 2012, laboratory tests revealed hematic level of PSA of
3.24 ng/mL. His value of PSA had tripled in only 3 months,
about 5 years after radical surgery and therapies.
After this unexpected increase, complete clinical exami-
nation of the patient happened to be negative, without any
skin alteration on the penile glans or any evidence of palpable
inguinal lymph nodes.interests exist.
right license from the University of Washington. This is an open
ns.org/licenses/by-nc-nd/4.0/).
Fig. 1 e CT scan on axial (A, B) and multiplanar reconstruction in the sagittal and coronal planes (C, D) detects a nodule on
the left side of corpus cavernosum (indicated by white arrow in all figures) with an early contrast enhancement after
iodinated contrast agent injection. In addition, CT reveals an ipsilateral hydrocele (D). CT, computed tomography.
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almost twice compared to June 2012.
Follow-up computed tomography (CT) scan did not reveal
anymetastatic localization in the abdomen, but scans showed
osteolytic areas: one area with osteolytic features was visu-
alized on the vertebral body of L2 and one on the left femur.
Bone scintigraphy confirmed the positivity of these
2 lesions. Thus, oral therapy with estramustine phosphate
was started.
During further follow-up, the patient did not complain any
local complications or penile pain, but a continuous increase
of his values of PSA was observed.
Nevertheless, the disease remained stable until January
2013 (PSA values of 8.07 ng/mL), when another CT examina-
tion showed an oval subcutaneous nodule (maximum diam-
eter 21 mm) that was located on the left margin of corpus
cavernosum. After injection of iodinated contrast agent, this
mass had homogenous and early contrast enhancement,
indicating high angiogenesis. Furthermore, left scrotal
hydrocele was observed (Fig. 1).
Magnetic resonance imaging (MRI) of the penis was
performed on a 1.5-T scanner (GyroscanIntera; PhilipsMedical
Systems, Best, The Netherlands) equipped with 8-channeldedicated coil. MRI images were acquired on axial, sagittal,
and coronal planes using T1-weighted and T1 spectral pre-
saturation with inversion recoveryeweighted sequences and
T2-weighted and T2 spectral presaturation with inversion
recoveryeweighted sequences; T1-weighted dynamic study
after injection of gadolinium was also performed. MRI
confirmed the previous findings, showing nodular area of
altered signal intensity, hypointense on T1-weighted and T2-
weighted sequences, characterized by an early and persis-
tent contrast enhancement on dynamic sequences after in-
jection of gadolinium (Fig. 2).
In February 2013, penile biopsy was performed. Pathology
report from biopsy specimens was fibromuscular adipose
tissue with infiltration of poorly differentiated carcinoma, all
positive for PSA at the immunohistochemistry (Fig. 3). Levels
of PSA at this time were 8.81 ng/mL.
In August 2013, values of PSA reached 13.57 ng/mL and
another bone scintigraphy revealed new sites of metastatic
localization.
Twelve months after the diagnosis of penile metastasis,
due to cardiologic toxicity and bad general conditions of the
patient, multidisciplinary group of our institution decided to
treat him with best supportive care. The patient died about
Fig. 2 e MRI T1-weighted images on the axial plane (A) and T2-weighted images on the axial and sagittal planes
(B, C) showing an oval-shaped area, hypointense on both sequences (white arrow) that is localized on the left side of
corpus cavernosum. On dynamic sequences, after paramagnetic contrast agent injection, the lesion shows early
contrast enhancement in the arterial phase (D), and persistent enhancement in the delayed phases (E, F). MRI,
magnetic resonance imaging.
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his bad general conditions.Discussion
Penile metastases are relatively uncommon, event though the
penis is provided by rich and complex vascular supply, well
connected to the pelvic organs. In 1870, Eberth [1] firstFig. 3 e Histologic findings of surgical biopsy. Fibromuscular tis
differentiated carcinoma (panel A, hematoxylin-eosin, 10£), sh
antigen antibody at the immunohistochemistry (panel B, 10£).described a case of penile metastasis. In 1997, a Japanese
Scientific Review reported only 110 described cases (Table 1).
About 75% of all cases originate from the genital tract [2].
Clinical signs and symptoms associated with penile me-
tastases are priapism, urinary retention, penile palpable
masses or skin alterations, pelvic and perineum pain, dysuria,
and hematuria [3].
Although prostatic carcinoma is the most common cancer
in males and the second leading cause of cancer-relatedsue characterized by an infiltration from a poorly
owing a positive reaction with the anti-prostate-specific
Table 1 e Primary sites of cancers metastasized to penis
(Japanese Scientific Review).
Primary sites N. patients (%)
Genitourinary tract 76 (69)
Bladder 32 (29)
Prostate 25 (23)
Kidney 11 (10)
Ureter 4 (3.6)
Testis 2 (1.8)
Urethra 2 (1.8)
Gastrointestinal systems 21 (19)
Rectum 12 (11)
Stomach 5 (4.5)
Esophagus 3 (2.7)
Cecum 1 (0.9)
Respiratory system 8 (7.2)
Lung 6 (5.4)
Other 2 (1.8)
Others 5 (4.5)
Total 110 (100)
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rare condition [4].
From a review of the latest literature, we could find 451
published cases of secondary penile metastasis, and among
these, only 33% had originated from prostate adenocarci-
noma. Primary tumor generally involved the genitourinary
tract (69%) followed by gastrointestinal cancer (19%). All
described cases were associated with very poor progno-
sisdvariable survival rates from 1 to 24 monthsdand in all
these cases, autopsy has identifiedmultiple coexistent sites of
metastasis in the patients [5e7]. Only 2 articles from the
recent literature have described a penile metastatic localiza-
tion from osteosarcoma and cholangiocarcinoma [8,9].
Typically, prostatic carcinoma metastasizes to local
regional lymphnodes and to the bone, but it can spread also to
lungs, bladder, liver, and adrenal glands. Classification for
prostatic cancer ismade using the Gleason score, based on the
degree of glandular differentiation and the pattern of tumor
growth (stromal component), as identified at relatively low
magnification [10]. Despite the proximity and his rich vascu-
larization, prostate carcinoma reaches the penis infrequently:
in 219 cases of penis metastases reported in the literature,
only 26 cases were secondary to prostatic cancer [5,11].
In the natural history of disseminated prostate cancer,
penilemetastasismay be a late presentation, and it is generally
associated with very poor prognosis: the literature reports that
41% of patients died within 6 months after the diagnosis [5,12].
Abeshouse et al [13] tried to explain the possible mecha-
nism of metastasis from prostate to penis as follows: (1) direct
invasion, (2) implantation, (3) dissemination through the
blood stream, and (IV) dissemination through lymphatic sys-
tem. The most likely route of spread is retrograde venous
transport because there are high chances of communication
between the pelvic venous plexuses and the penile dorsal
venous system [13]. This way of spreading could explain why
penile erectile tissues, mainly corpora cavernosa are prefer-
entially involved.
Typically, metastases occur in the central portion of the
corpus cavernosum or spongiosum, and this distinguishesthem from primary penile lesions; in particular, squamous
cell carcinoma, which represents 95% of primary tumors of
the penis, is mainly localized at glans. When diagnosed, most
of these cases are associated with disseminated disease, and
patients usually present with priapism, painful nodule (Peyr-
onie's disease), and urinary obstruction. The typical occur-
rence of priapism is due to metastatic replacement of corpora
cavernosa by the tumor, with blockage of the venous blood
flow and lasting painful erection. Differential diagnosis should
include primary penile tumors, chancre, tuberculosis, and
nonspecific inflammatory lesions.
In prostatic cancer, the clinicalmanagement and follow-up
is aided by laboratory testing of values of PSA and radiologic
examinations.
Serum levels of PSA enable not only the early detection of
prostatic adenocarcinoma but also the identification of even-
tual metastases during follow-up [14]. Despite this, we could
find in the literature, a reported case of penile metastases
without any increase of PSA levels [15,16].
Radiologic diagnosis of penile metastasis involves several
steps: CT scan has an important role for the detection of
secondary lesions at diagnosis and during the follow-up. MRI
represents the most reliable technique in the differentiation
of penile lesions and for staging: due to its soft-tissue contrast
high capability, it can evaluate the invasion of tunica albu-
ginea, corpora, and urethra. Typical MRI features of penile
metastases are hypointensity on both T1- and T2-weighted
sequences and nonspecific enhancement after gadolinium
injection [17].
Currently the use of ultrasound has not been standardized
yet.
The final diagnosis is made by needle core biopsy.
Our case is extremely rare: a presentation of penile
metastasis 6 years after radical prostatectomy has not been
previously reported in the literature. The average interval of
presentation of penile metastatic localizations is reported to
be about 38-50 months after the first diagnosis of prostate
carcinoma [18].
In conclusion, metastatic prostatic cancer may present
different localizations, including penile structures. Despite
the rarity of this disease, considering its poor prognosis and its
capability to metastasize after several years, it emerges the
crucial role of radiologic examinations during oncologic
follow-up, especially after significant increases of PSA levels.
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